Hepatocellular carcinoma and food contamination: Ochratoxin a as a great prompter

World Journal of Gastroenterology

Volumn 19, Issue 24, 2013, Pages 3723-3725

  Felizardo, Raphael J F ^a   Câmara, Niels O S ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Egypt; Food contamination; Hepatocellular carcinoma; Liver cancer; Mycotoxin; Ochratoxin A

Indexed keywords

AFLATOXIN; OCHRATOXIN;

ARTICLE; ASPERGILLUS; CONTROLLED STUDY; FOOD CONTAMINATION; GOOD MANUFACTURING PRACTICE; HUMAN; INTERSTITIAL NEPHRITIS; LIVER CELL CARCINOMA; NONHUMAN; PENICILLIUM;

EID: 84879597414     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i24.3723     Document Type: Article

References (21)

1. El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med 2007; 167: 1983-1989[PMID: 17923599 DOI: 10.1001/archinte.167.18.1983]
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576[PMID: 17570226 DOI: 10.1053/j.gastro. 2007.04.061]
3. Wolfson IN. Letter: Blind defbrillation. Am J Cardiol 1975; 36: 412[PMID: 1166849 DOI: 10.1002/ijc.1440]
4. Yu MC, Yuan JM. Environmental factors and risk for he-patocellular carcinoma. Gastroenterology 2004; 127: S72-S78[PMID: 15508106 DOI: 10.1016/j.gastro.2004.09.018]
5. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010; 15 Suppl 4: 5-13[PMID: 21115576 DOI: 10.1634/theoncologist.2010-S4-05]
6. Zidan A, Scheuerlein H, Schüle S, Settmacher U, Rauchfuss F. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide. Hepat Mon 2012; 12: e6894[PMID: 23233864 DOI: 10.5812/hepatmon.6894]
7. Farazi PA, DePinho RA. Hepatocellular carcinoma patho-genesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-687[PMID: 16929323 DOI: 10.1038/nrc1934]
8. Groopman JD, Cain LG, Kensler TW. Afatoxin exposure in human populations: measurements and relationship to cancer. Crit Rev Toxicol 1988; 19: 113-145 [PMID: 3069332 DOI: 10.3109/10408448809014902]
9. Wild CP, Turner PC. The toxicology of afatoxins as a basis for public health decisions. Mutagenesis 2002; 17: 471-481[PMID: 12435844 DOI: 10.1093/mutage/17.6.471]
10. Wild CP, Hudson GJ, Sabbioni G, Chapot B, Hall AJ, Wogan GN, Whittle H, Montesano R, Groopman JD. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev 1992; 1: 229-234[PMID: 1339083 DOI: 10.1289/ehp.9302]
11. Gan LS, Skipper PL, Peng XC, Groopman JD, Chen JS, Wo-gan GN, Tannenbaum SR. Serum albumin adducts in the molecular epidemiology of afatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis 1988; 9: 1323-1325[PMID: 3133131 DOI: 10.1093/carcin/9.7.1323]
12. Ibrahim AS, Zaglol MH, Badria FA. Case Report Evidence of Relationships Between Hepatocellular Carcinoma and Ochratoxicosis. [Unpublished raw data]
13. Harris JP, Mantle PG. Biosynthesis of ochratoxins by As-pergillus ochraceus. Phytochemistry 2001; 58: 709-716[PMID: 11672735 DOI: 10.1016/S0031-9422(01)00316-8]
14. Pfohl-Leszkowicz A, Manderville RA. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 2007; 51: 61-99[PMID: 17195275 DOI: 10.1002/mnfr.200600137]
15. Reddy L, Bhoola K. Ochratoxins-food contaminants: impact on human health. Toxins (Basel) 2010; 2: 771-779[PMID: 22069609 DOI: 10.3390/toxins2040771]
16. Boorman GA, McDonald MR, Imoto S, Persing R. Renal lesions induced by ochratoxin A exposure in the F344 rat. Tox-icol Pathol 1992; 20: 236-245[PMID: 1475584 DOI: 10.1177/ 019262339202000210]
17. Kamp HG, Eisenbrand G, Janzowski C, Kiossev J, Laten-dresse JR, Schlatter J, Turesky RJ. Ochratoxin A induces oxi-dative DNA damage in liver and kidney after oral dosing to rats. Mol Nutr Food Res 2005; 49: 1160-1167[PMID: 16302199 DOI: 10.1002/mnfr.200500124]
18. Gagliano N, Donne ID, Torri C, Migliori M, Grizzi F, Milzani A, Filippi C, Annoni G, Colombo P, Costa F, Ceva-Grimaldi G, Bertelli AA, Giovannini L, Gioia M. Early cytotoxic effects of ochratoxin A in rat liver: a morphological, biochemical and molecular study. Toxicology 2006; 225: 214-224[PMID: 16857307 DOI: 10.1016/j.tox.2006.06.004]
19. Tozlovanu M, Canadas D, Pfohl-Leszkowicz A, Frenette C, Paugh RJ, Manderville RA. Glutathione conjugates of och-ratoxin A as biomarkers of exposure. Arh Hig Rada Toksikol 2012; 63: 417-427[PMID: 23334036 DOI: 10.2478/10004-1254 -63-2012-2202]
20. Li ZW, Bijl WA, van Nispen JW, Brendel K, Davis TP. Neuropeptide processing in regional brain slices: effect of conformation and sequence. J Pharmacol Exp Ther 1990; 253: 851-857[PMID: 2140132 DOI: 10.3109/10408444.2010. 529105]
21. Wu Q, Dohnal V, Huang L, Kuča K, Wang X, Chen G, Yuan Z. Metabolic pathways of ochratoxin A. Curr Drug Metab 2011; 12: 1-10[PMID: 21222585 DOI: 10.2174/1389200117945 20026]